Fertility Tourism Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The global fertility tourism market encompasses services such as IVF, egg and sperm donation, surrogacy arrangements, and fertility preservation that patients pursue in countries other than their own. Private market research firms estimate the market was worth approximately $1.6-2.6 billion in 2024-2025, with projections varying by methodology and forecast horizon. No government or official statistical agency publishes dedicated fertility tourism market size data, meaning all figures are derived from commercial industry analysts rather than official sources.

• •Private estimates place 2025 market size between $1.74 billion and $2.6 billion depending on the research firm
• •No government or official statistical agency publishes standalone fertility tourism market figures
• •Market research firms consistently project strong double-digit growth through at least 2030

Rising global infertility rates, linked to delayed childbearing, lifestyle factors, and environmental conditions, have expanded the pool of prospective patients seeking treatment options beyond their home countries. Significant cost differentials remain a primary motivator: IVF cycles can cost two to three times more in the United States than in countries such as the Czech Republic, Greece, or Mexico. Additionally, legal barriers including bans or restrictions on egg donation, surrogacy, and certain embryo practices in jurisdictions across Europe and North America push patients toward destinations with more permissive regulatory environments.

• •IVF treatment costs in the U.S. can exceed $15,000 per cycle, while comparable treatment in some European destinations may cost under $5,000
• •Countries such as Ukraine, Georgia, and India have positioned themselves as surrogacy destinations due to favorable legal frameworks
• •Growing numbers of patients are researching international fertility options online, accelerating market awareness and demand

The market is typically segmented by treatment type, including IVF with or without donor gametes, surrogacy, and fertility preservation, as well as by patient origin and destination country. Europe dominates both as a source region, driven by long public healthcare wait times and restrictive laws, and as a destination, with countries such as the Czech Republic, Spain, Greece, and Portugal attracting patients from Western Europe, the UK, and beyond. Asia-Pacific, particularly Thailand, India, and Malaysia, has historically been a significant destination market, though regulatory changes in some countries have shifted patterns. North America remains the largest single-country source market for outbound fertility tourism, while Latin America and Eastern Europe are emerging destination markets.

• •Europe serves as both the primary source region for patients and a leading destination cluster for fertility treatments
• •The surrogacy segment represents a high-value sub-market, with Ukraine, Georgia, and previously India as key destinations
• •IVF and egg donation treatments account for the largest share of fertility tourism services by procedure volume

What are the recent trends and outlook?

The market is expected to continue its strong growth trajectory, with most analysts projecting values between $5.76 billion and $6.18 billion by 2030, representing roughly 24-30% compound annual growth depending on the firm and measurement scope. Key trends include increasing digitalization of patient education and clinic discovery, growing use of telemedicine consultations before travel, and heightened regulatory scrutiny that may reshape popular destinations. Legal and ethical debates surrounding surrogacy and egg donation in key markets are likely to influence destination rankings going forward, while emerging destinations in Eastern Europe, Southeast Asia, and Latin America are capturing growing market share. Long-term demand remains underpinned by the global fertility crisis and persistent access and cost barriers in many high-income countries.

• •Most analysts forecast the market to reach $5.76-6.18 billion by 2030 at a 23-30% CAGR depending on methodology
• •Shifting regulations in surrogacy-heavy destinations are redirecting patient flows toward alternative markets
• •Digital platforms and telemedicine are reducing the information gap for patients considering treatment abroad